These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2910411)

  • 1. Value of venous catheterization and calcitonin studies in the treatment and management of clinically inapparent medullary thyroid carcinoma.
    Ben Mrad MD; Gardet P; Roche A; Rougier P; Calmettes C; Motte P; Parmentier C
    Cancer; 1989 Jan; 63(1):133-8. PubMed ID: 2910411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid venous catheterization in the early diagnosis of familial medullary thyroid carcinoma.
    Wells SA; Baylin SB; Johnsrude IS; Harrington DP; Mendelsohn G; Ontjes DJ; Cooper CW
    Ann Surg; 1982 Nov; 196(5):505-11. PubMed ID: 7125737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromogranin A as tumor marker in medullary thyroid carcinoma.
    Blind E; Schmidt-Gayk H; Sinn HP; O'Connor DT; Raue F
    Thyroid; 1992; 2(1):5-10. PubMed ID: 1356053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma.
    Pacini F; Fontanelli M; Fugazzola L; Elisei R; Romei C; Di Coscio G; Miccoli P; Pinchera A
    J Clin Endocrinol Metab; 1994 Apr; 78(4):826-9. PubMed ID: 8157706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma.
    Barbot N; Calmettes C; Schuffenecker I; Saint-André JP; Franc B; Rohmer V; Jallet P; Bigorgne JC
    J Clin Endocrinol Metab; 1994 Jan; 78(1):114-20. PubMed ID: 7904611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urine calcitonin as a test for medullary thyroid cancer: a new screening procedure.
    Silva OL; Snider RH; Moore CF; Becker KL
    Ann Surg; 1979 Mar; 189(3):269-74. PubMed ID: 426557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules.
    Costante G; Meringolo D; Durante C; Bianchi D; Nocera M; Tumino S; Crocetti U; Attard M; Maranghi M; Torlontano M; Filetti S
    J Clin Endocrinol Metab; 2007 Feb; 92(2):450-5. PubMed ID: 17119000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization of occult persisting medullary thyroid carcinoma before microsurgical reoperation: high sensitivity of selective venous catheterization.
    Frank-Raue K; Raue F; Buhr HJ; Baldauf G; Lorenz D; Ziegler R
    Thyroid; 1992; 2(2):113-7. PubMed ID: 1525578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization and resection of clinically inapparent medullary carcinoma of the thyroid.
    Norton JA; Doppman JL; Brennan MF
    Surgery; 1980 Jun; 87(6):616-22. PubMed ID: 7376073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of pentagastrin test for preoperative differential diagnosis between C-cell hyperplasia and medullary thyroid carcinoma in patients with moderately elevated basal calcitonin levels.
    Milone F; Ramundo V; Chiofalo MG; Severino R; Paciolla I; Pezzullo L; Lombardi G; Colao A; Faggiano A
    Clin Endocrinol (Oxf); 2010 Jul; 73(1):85-8. PubMed ID: 20039894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcitonin as a tumor marker. Use of the radioimmunoassay for calcitonin in the postoperative evaluation of patients with medullary thyroid carcinoma.
    Goltzman D; Potts JT; Ridgway RC; Maloof F
    N Engl J Med; 1974 May; 290(19):1035-9. PubMed ID: 4207025
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of thyrocalcitonin for the detection of familial medullary cancers in children].
    Calmettes C
    Ann Med Interne (Paris); 1984; 135(5):335-7. PubMed ID: 6486612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PDN-21 (katacalcin) and chromogranin A: tumor markers for medullary thyroid carcinoma.
    Raue F; Blind E; Grauer A
    Henry Ford Hosp Med J; 1992; 40(3-4):296-8. PubMed ID: 1483876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum calcitonin negative medullary thyroid carcinoma: a systematic review of the literature.
    Trimboli P; Giovanella L
    Clin Chem Lab Med; 2015 Sep; 53(10):1507-14. PubMed ID: 25781697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Medullary cancer of the thyroid and hyperthyrocalcitonin syndrome].
    Milhaud G; Coutris G; Tubiana M
    Presse Med (1893); 1969 Dec; 77(56):2129-32. PubMed ID: 5374252
    [No Abstract]   [Full Text] [Related]  

  • 16. Selective venous sampling catheterisation for localisation of persisting medullary thyroid carcinoma.
    Abdelmoumene N; Schlumberger M; Gardet P; Roche A; Travagli JP; Francese C; Parmentier C
    Br J Cancer; 1994 Jun; 69(6):1141-4. PubMed ID: 8198983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels.
    Iacobone M; Niccoli-Sire P; Sebag F; De Micco C; Henry JF
    World J Surg; 2002 Aug; 26(8):886-90. PubMed ID: 12016469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative predictive value of procalcitonin in medullary thyroid carcinoma.
    Lim SK; Guéchot J; Vaubourdolle M
    Ann Biol Clin (Paris); 2016; 74(2):213-8. PubMed ID: 26806393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Calcitonin determination as a possibility for the evaluation of surgical result in medullary thyroid carcinoma (C-cell carcinoma)].
    Horn J; Pfarr B; Ziegler R
    Langenbecks Arch Chir; 1975; Suppl():231-4. PubMed ID: 1207235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d'Etudes des Tumeurs a Calcitonine (GETC).
    Cohen R; Campos JM; Salaün C; Heshmati HM; Kraimps JL; Proye C; Sarfati E; Henry JF; Niccoli-Sire P; Modigliani E
    J Clin Endocrinol Metab; 2000 Feb; 85(2):919-22. PubMed ID: 10690910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.